Limnopharma was selected as one of the 10 companies presenting at the I Life Science Investor Capital Forum. The event, held in the Parc Científic (Barcelona), was sponsored by Foro Capital Pymes, Canaan R&I, Keiretsu Forum and Parc Científic de Barcelona. During this event we presented our project to investor groups with capacity for funding above 0,5M € per project.
Recent Posts
- A breakthrough in the battle against blindness: Limnopharma’s latest discovery
- Limnopharma named one of the 100 best startups of 2023
- Confirmation of Lim21 mechanism of action
- The Fight Against Blindness Foundation presents the winner of the FUNDALUCE 2022 Awards
- Limnopharma Participation in Biotechnology Fairs and Investment Events.